Physician profile
Stuart E Hisler
NPI 1053307561
$1,915.24
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,556 · 2020: $332 · 2021: $26.62.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $394.32 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $361.54 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $269.63 | 2019-2020 | |
| Lilly USA, LLC | $177.41 | 2019-2020 | |
| Glaxosmithkline, LLC. | $137.99 | 2019-2021 | |
| Novo Nordisk INC | $129.63 | 2019-2020 | |
| Pfizer INC. | $108.64 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $98.58 | 2019 | |
| Amarin Pharma, INC. | $80.33 | 2019-2020 | |
| Allergan, INC. | $71.55 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $35.02 | 2019 | |
| Sanofi-Aventis U.S. LLC | $31.78 | 2019-2020 | |
| Sanofi Pasteur INC. | $18.82 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Hisler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.